New products
Our product range is growing thanks to researcher and customer suggestions. Our new products range from everyday, commonly used products introduced at prices around 50% less than other suppliers, to novel exclusive research tools. And you can be sure that all of our new products are of the highest quality and standard.
Keep up-to-date with our new low-cost products | Suggest a new product for a free trial
Clozapine N-oxide (CNO) (freebase) (HB1807)
Description:Prototypical DREADD activator. Clozapine metabolite.
Purity:>98%
- Description:
Dihydrochloride salt of CNO - the prototypical DREADD activator
Purity:>98%
-
Diphenhydramine hydrochloride (DPH) (HB2617)
Description:Histamine H1 antagonist. Potent actuator of a modified hM4Di "GRANPA" DREADD receptor.
Purity:>99%
- Description:
Novel, selective activator of the peripherally restricted HCAD DREADD. Does not cross the BBB.
Purity:>99%
- Description:
Novel, selective activator of the peripherally restricted HCAD DREADD. Does not cross the BBB. Water soluble.
Purity:>98%
-
Perlapine (HB4889)
Description:Effective agonist for muscarinic-based DREADDs in vitro and in vivo. Non-CNO chemogenetic actuator
Purity:>98%
- Description:
Effective agonist for muscarinic-based DREADDs in vitro and in vivo. Non-CNO chemogenetic actuator. Water soluble.
Purity:>98%
-
-
![FCH-2296413 sodium (Peripherally restricted HCAD DREADD actuator) [Water Soluble]](https://cdn.hellobio.com/media/catalog/product/cache/7630ee9852b6c22c7de1165054afc779/h/b/hb10013.png)
